SKK
ALBO

Shepherd Kaplan Krochuk’s Albireo Pharma Inc ALBO Stock Holding History

Shepherd Kaplan Krochuk’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-2,701
Closed -$27K – 366
2016
Q1 		$27K Sell
2,701
-1,183
-30% -$10.5K 0.01% 284
2015
Q4 		$40K Buy
3,884
+866
+29% +$8.96K 0.01% 371
2015
Q3 		$40K Sell
3,018
-633
-17% -$15.9K 0.01% 371
2015
Q2 		$113K Sell
3,651
-267
-7% -$8.97K 0.02% 360
2015
Q1 		$140K Buy
3,918
+1,234
+46% +$52K 0.02% 324
2014
Q4 		$107K Buy
2,684
+510
+23% +$22.4K 0.02% 415
2014
Q3 		$109K Sell
2,174
-184
-8% -$10.6K 0.01% 489
2014
Q2 		$153K Hold
2,358
– – 0.02% 474
2014
Q1 		$193K Hold
2,358
– – 0.02% 458
2013
Q4 		$161K Buy
2,358
+1,767
+299% +$129K 0.02% 454
2013
Q3 		$56K Sell
591
-133
-18% -$17.3K 0.01% 542
2013
Q2 		$91K Buy
+724
New +$75.3K 0.02% 528

Other funds holding ALBO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PVH
Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Shepherd Kaplan Krochuk's ALBO Position: Q2 2016 in Review

Shepherd Kaplan Krochuk sold out of Albireo Pharma Inc (ALBO) in Q2 2016, closing a stake of 2,701 shares — an estimated $27K sold.

Shepherd Kaplan Krochuk first reported a position in ALBO in Q2 2013 and held it in 12 quarters. The position peaked at $193K in Q1 2014. 24 funds tracked by Wall St. Rank hold ALBO as of Q2 2016.

  • Shepherd Kaplan Krochuk reported no remaining Albireo Pharma Inc position as of Q2 2016 after selling out during the quarter.
  • Shepherd Kaplan Krochuk sold 2,701 Albireo Pharma Inc shares in Q2 2016, an estimated $27K.
  • Shepherd Kaplan Krochuk first reported a position in Albireo Pharma Inc in Q2 2013 and held it in 12 quarters.
  • Shepherd Kaplan Krochuk's Albireo Pharma Inc position peaked at $193K in Q1 2014.
  • 24 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q2 2016.

Based on Shepherd Kaplan Krochuk's 13F filing for Q2 2016, filed 15 Aug 2016.